Study Finds Hospitals Reduce Pediatric Patient Length of Stay by 25% by Deploying Etiometry Risk Analytics
News and Press Releases
Results of a Multi-Center, Retrospective Cohort Analysis of All Neonates Admitted to the CICU at Boston Children’s Hospital and the Hospital for Sick Children, Toronto
BOSTON, December 19, 2017—Etiometry, a pioneering leader in next-generation patient monitoring, announced today that a study presented in the American Heart Association (AHA) Scientific Sessions 2017 demonstrates the capability of the Etiometry Platform to significantly reduce hospitals intensive care unit costs.
The Impact of a Real-Time Physiologic Data Analytic Index on Length of Stay in Neonates Following Surgery for Congenital Heart Disease abstract presented results from a retrospective study conducted in the first two hospitals that adopted Etiometry’s Inadequate Delivery of Oxygen (IDO2) Index. The study was co-authored by: Dr. Josh Salvin, Boston Children’s Hospital; Dr. Peter Laussen MBBS FCICM, The Hospital for Sick Children, Toronto; and Dr. Dimitar Baronov, PhD, Etiometry’s CTO. It demonstrates a statistically significant 25% reduction of length of stay (LOS) for the neonates admitted for cardiac intensive care in the two hospitals.
According to Etiometry’s COO Evan Butler, “There is a wide expectation in the clinical community that impactful information technology and actionable data analytics should bring much-needed reduction in hospital costs and improvement in patient outcomes. We are proud to see our Etiometry Platform leading the way in proving these expectations by demonstrating measurable positive impact in an especially vulnerable patient population.”
The Etiometry Platform consists of three software components: T3 Data Aggregation & Visualization, Risk Analytics Algorithms, and Quality Improvement System. They are integrated to support clinical use cases, such as meaningful workflow integration and streamlined measurement of care impact. For more information, send an email to info@etiometry.com and request the Etiometry ROI whitepaper.About Etiometry
Etiometry Inc. is the leader in clinical decision-support software for the intensive care environment. Our technologies provide valuable clinical insight and analysis to support early recognition of subtle changes in patient condition to avoid complications and speed recovery. Etiometry is committed to improving patient outcomes, increasing clinical efficiency, and lowering costs of care through the more effective use of all available data.
For more information, visit www.etiometry.com.
We’d love to hear from you
Whether you’re curious about how Etiometry can help support your team, the platform’s latest outcomes data or a demo – we’re ready to answer your questions.
Contact UsRelated
First Automated Hospital-Specific Cardiogenic Shock Classification Tool for Critical Care Teams
Etiometry has received FDA clearance (K254066) for the Etiometry Cardiogenic Shock Tool: the first-ever automated solution for hospital-specific cardiogenic shock classification and tracking (aligned with each institution’s own protocols) using physiologic monitoring data. This is Etiometry’s 11th FDA clearance overall, and the only solution that automates SCAI staging directly from physiologic monitoring data. For cardiac […]
The Business Case for Clinical Intelligence in the ICU. Is it a Worthwhile Investment?
Hospital operating margins remain thin and ICU cost is one of the largest line items in any high-acuity hospital. Clinical intelligence software, used as adjunctive support for clinician-directed care, has been associated with shorter ICU length of stay, fewer unplanned readmissions, and reduced ventilation time. Despite this, many senior hospital leaders are unsure of the […]
What is Clinical Intelligence Software and is it Ready for Clinical Reality?
ICU environments generate high volumes of physiologic data and alerts. “Alarm fatigue” is well documented in the literature, and it is linked to desensitisation, missed deterioration signals, and worse patient outcomes1. Clinical intelligence software can help here. It processes patient data continuously and highlights the risk signals that clinicians have defined as important, so teams […]